TrialJournal of translational medicine2010

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.

Chrystelle Brignone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.